Product NDC: | 59630-170 |
Proprietary Name: | Zebutal |
Non Proprietary Name: | Butalbital, acetaminophen and caffeine |
Active Ingredient(s): | 500; 50; 40 mg/1; mg/1; mg/1 & nbsp; Butalbital, acetaminophen and caffeine |
Administration Route(s): | ORAL |
Dosage Form(s): | CAPSULE |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 59630-170 |
Labeler Name: | Shionogi Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA040261 |
Marketing Category: | ANDA |
Start Marketing Date: | 19981028 |
Package NDC: | 59630-170-11 |
Package Description: | 100 CAPSULE in 1 BOTTLE (59630-170-11) |
NDC Code | 59630-170-11 |
Proprietary Name | Zebutal |
Package Description | 100 CAPSULE in 1 BOTTLE (59630-170-11) |
Product NDC | 59630-170 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Butalbital, acetaminophen and caffeine |
Dosage Form Name | CAPSULE |
Route Name | ORAL |
Start Marketing Date | 19981028 |
Marketing Category Name | ANDA |
Labeler Name | Shionogi Inc. |
Substance Name | ACETAMINOPHEN; BUTALBITAL; CAFFEINE |
Strength Number | 500; 50; 40 |
Strength Unit | mg/1; mg/1; mg/1 |
Pharmaceutical Classes | Barbiturate [EPC],Barbiturates [Chemical/Ingredient],Central Nervous System Stimulant [EPC],Central Nervous System Stimulation [PE],Methylxanthine [EPC],Xanthines [Chemical/Ingredient] |